- Home
- HBNC vs YDES Comparison
HBNC vs YDES Comparison
Compare HBNC & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HBNC | YDES |
|---|---|---|
| Founded | 1873 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.5M | 894.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HBNC | YDES |
|---|---|---|
| Price | $17.35 | $12.00 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.33 | N/A |
| AVG Volume (30 Days) | ★ 338.5K | 63.1K |
| Earning Date | 01-21-2026 | 09-30-2025 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $510,360.00 |
| Revenue This Year | $51.78 | N/A |
| Revenue Next Year | $7.75 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.91 | ★ 45.76 |
| 52 Week Low | $12.70 | $5.30 |
| 52 Week High | $19.07 | $31.00 |
Technical Indicators
Market Signals| Indicator | HBNC | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 51.02 | 48.53 |
| Support Level | $17.05 | $11.74 |
| Resistance Level | $19.07 | $12.50 |
| Average True Range (ATR) | 0.54 | 0.73 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 40.75 | 63.14 |
Price Performance
Historical ComparisonAbout HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About YDES YD Bio Limited Ordinary Shares
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.